New Insights on the Nature of Latent Tuberculosis Infection and its Treatment

Publisher： Bentham Science Publishers

E-ISSN： 2212-4055|6|1|27-39

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.6, Iss.1, 2007-03, pp. : 27-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection

By Stout Jason E  

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 187-198

Informa Healthcare

Access to resources Recommend Favorite

Host-Pathogen Interactions in Latent Mycobacterium tuberculosis Infection: Identification of New Targets for Tuberculosis Intervention

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 8, Iss. 1, 2008-03 ,pp. : 15-29

Bentham Science Publishers

Access to resources Recommend Favorite

Tuberculosis and its Treatment: An Overview

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 1, 2017-12 ,pp. : 58-71

Bentham Science Publishers

Access to resources Recommend Favorite

Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 887-8013, Iss. 5, 2015-09 ,pp. : 375-382

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection

By  

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 29, Iss. 5, 2015-09 ,pp. : 375-382

John Wiley & Sons Inc

Access to resources Recommend Favorite